Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder | Zendy

Oliver Scholle | Zendy; Tobias Banaschewski | Zendy; Dirk Enders | Zendy; Edeltraut Garbe | Zendy; Oliver Riedel | Zendy

Open Access

Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder

Author(s) -

Oliver Scholle,

Tobias Banaschewski,

Dirk Enders,

Edeltraut Garbe,

Oliver Riedel

Publication year - 2018

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2018.0024

Subject(s) - risperidone , methylphenidate , tiapride , attention deficit hyperactivity disorder , psychiatry , antipsychotic , medicine , concomitant , population , psychology , pediatrics , schizophrenia (object oriented programming) , environmental health

Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) frequently have comorbidities that are potential indications for antipsychotics (APs). Some studies have suggested that the combined use of methylphenidate (MPH) and APs is increasing in this population group. Longitudinal analyses and in-depth investigations on the substance level are lacking. This study aimed to estimate the cumulative proportion of concomitant AP/MPH use in children and adolescents with ADHD over a follow-up of up to 9 years and to describe patient characteristics stratified by specific AP drug.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research